Hiroki Takahata

Prof. Hiroki Takahata


Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AKAtsushi Kato
Atsushi Kato
EHErina Hayashi
Erina Hayashi
SMSaori Miyauchi
Saori Miyauchi
IAIsao Adachi
Isao Adachi
TITatsushi Imahori
Tatsushi Imahori
HTHiroki Takahata
Hiroki Takahata

2 April 2003 in The Journal of Organic Chemistry
Verified
Journal Article
Closed access
HTHiroki Takahata
Hiroki Takahata
YBYasunori Banba
Yasunori Banba
HOHidekazu Ouchi
Hidekazu Ouchi
HNHideo Nemoto
Hideo Nemoto
AKAtsushi Kato
Atsushi Kato
IAIsao Adachi
Isao Adachi

14 March 2006 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
HTHiroki Takahata
Hiroki Takahata
YSYukako Saito
Yukako Saito
MIMotohiro Ichinose
Motohiro Ichinose
A novel C2-symmetric 2,6-diallylpiperidine carboxylic acid methyl ester 1 was prepared by the double asymmetric allylboration of glutaldehyde followed by an aminocyclization and carbamation. On the basis of desymmetrization of 1 using iodocarbamation, one allyl group of 1 was protected and monofunctionalizations of the resulting oxazolidinone 11 were performed. The reaction of the N-methoxycarbonyl piperidine 25 employing decarbamation reagent (n-PrSLi or TMSI) as a key step gave oxazolidinone 26 or 17 including an intramolecular ring formation, which was transformed in a few steps into (−)-porantheridine (2) and (−)-2-epi-porantheridine (3), respectively. In addition, the expedient synthesis of (+)-epi-dihydropinidine (4), (2R,6R)-trans-solenopsin A (5), and precoccinelline (6), starting from 11 is described.

1 January 1989 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
PDF file
HTHiroki Takahata
Hiroki Takahata
MTMayumi Tajima
Mayumi Tajima
YBYasunori Banba
Yasunori Banba
TMTakefumi Momose
Takefumi Momose
Mercuric acetate driven cyclization of γ-hydroxy-δ, ε-unsaturated urethanes 1a, b proceeded regio- and stereoselectively to afford cis-2-acetoxymercurymethyl-3-hydroxypyrrolidines 2a, b, respectively. These were transformed into the key intermediates for several biologically active compounds.

14 January 2005 in Tetrahedron Letters
Verified
Journal Article
Closed access
YSYukako Saito
Yukako Saito
TYToru Yamaki
Toru Yamaki
FKFumiaki Kohashi
Fumiaki Kohashi
TWTomokazu Watanabe
Tomokazu Watanabe
HOHidekazu Ouchi
Hidekazu Ouchi
HTHiroki Takahata
Hiroki Takahata

16 January 2013 in Molecules
Verified
Journal Article
Open access
PDF file
YSYukako Saito
Yukako Saito
YYYuichi Yoshimura
Yuichi Yoshimura
HWHideaki Wakamatsu
Hideaki Wakamatsu
HTHiroki Takahata
Hiroki Takahata
Synthesis of beneficial protected meso-DAP 9 by cross metathesis of the Garner aldehyde-derived vinyl glycine 1b with protected allyl glycine 2 in the presence of Grubbs second-generation catalyst was performed. Preparation of lipophilic N-acyl iE-DAP as potent agonists of NOD 1-mediated immune response from 9 is described.